FDFT1 and urinary bladder cancer: Interestingly, FDFT1 is also among the top 10% genes overexpressed in bladder cancers that are sensitive to the anti-tumour drugs vandetanib and tipifarnib [17, 67] and in esophageal cancer cell lines that are sensitive to docetaxel, paclitaxel, and doxorubicin [68].